St. Jude Medical Announces First Implant In Its Migraine Headache Study

ST. PAUL, Minn.--(BUSINESS WIRE)--April 18, 2006--St. Jude Medical, Inc. (NYSE:STJ - News) today announced the implant of the first patient in its ESCAPE (Effect of Septal Closure of Atrial PFO on Events of Migraine with Premere(TM)) migraine trial.